EUVIMEDEUVIMED entdecken
Crossref

Plasma metabolomic profiling and functional disability in older adults

Andrés Pombo-Jiménez iD, Damián González-Beltrán iD, Humberto Yévenes-Briones iD, José R Banegas, Fernando Rodríguez-Artalejo, Esther Lopez-Garcia iD, Francisco Félix Caballero iD

The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 07.04.2026 · 81 (5)

DOI: 10.1093/gerona/glag054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, online erschienen am 22.02.2026. Verfasst von Andrés Pombo-Jiménez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive Medicine and Public Health, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain. Hauptthemen laut MEDLINE: Activities of Daily Living, Metabolomics, Persons with Disabilities, Aging. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Instituto de Salud Carlos III through the FIS, Instituto de Salud Carlos III, State Secretary of R + D+I.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Functional disability is a major public health concern in older adults, predicting adverse outcomes such as hospitalization, institutionalization, and mortality. While previous studies have linked metabolomic profiles to aging-related conditions, their relationship with functional disability remains unclear.

Methods

This study examined associations between plasma metabolomic profiles and functional disability in 1450 community-dwelling adults aged ≥65 years from the Seniors-ENRICA 2 cohort. Disability was assessed using the Katz Index for activities of daily living (ADL disability) and the Lawton-Brody Scale for instrumental activities of daily living (IADL disability). Twenty-seven metabolites quantified by high-throughput nuclear magnetic resonance spectroscopy were included in the analyses. Firth logistic regression estimated cross-sectional and 5-year longitudinal associations, adjusting for sociodemographic and lifestyle factors.

Results

Higher concentrations of tyrosine (odds ratio [OR] = 0.77; 95% confidence interval [CI]: 0.61-0.98), pyruvate (0.69; 0.50-0.95), and lactate (0.78; 0.61-0.98) were cross-sectionally associated with lower odds of ADL disability, whereas glycine (1.31; 1.05-1.64) and Glycoprotein A (GlycA) (1.47; 1.17-1.86) were linked to greater odds. After 5 years, higher lactate (1.17; 1.00-1.37) was associated with increased ADL disability, whereas creatinine predicted lower odds of ADL (0.80; 0.65-0.97) and IADL disability (0.68; 0.47-0.98). In incident disability analyses, higher creatinine (0.76; 0.62-0.94) and citrate (0.79; 0.66-0.94) concentrations predicted lower odds of ADL disability, while GlycA (1.36; 1.01-1.84) remained associated with higher odds of IADL disability.

Conclusions

These findings suggest that several plasma metabolites may serve as early biomarkers of functional decline and inform prevention strategies in older adults.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Activities of Daily LivingMetabolomicsPersons with DisabilitiesAgingHumansAgedFemaleMaleCross-Sectional StudiesDisability EvaluationBiomarkersAged, 80 and overGeriatric AssessmentLongitudinal StudiesAging in PlaceMagnetic Resonance Spectroscopy

Stichwörter der Autor:innen

Activities of daily livingAgingFunctional disabilityInstrumental activities of daily livingMetabolomic profiling

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Preventive Medicine and Public Health, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
  • CIBER of Epidemiology and Public Health, Instituto de Salud Carlos III, Madrid, Spain.
  • IMDEA-Food Institute, CEI UAM+CSIC, Madrid, Spain.

ORCID-Profile: Andrés Pombo-Jiménez, Damián González-Beltrán, Humberto Yévenes-Briones, Esther Lopez-Garcia, Francisco Félix Caballero

Förderung

  • Instituto de Salud Carlos III through the FIS
  • Instituto de Salud Carlos III
  • State Secretary of R + D+I
  • European Regional Development Fund
  • A way of shaping Europe

Zitieren

APA

Pombo-Jiménez, A., González-Beltrán, D., Yévenes-Briones, H., Banegas, J. R., Rodríguez-Artalejo, F., Lopez-Garcia, E., & Caballero, F. F. (2026). Plasma metabolomic profiling and functional disability in older adults. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 81(5). https://doi.org/10.1093/gerona/glag054

Vancouver

Pombo-Jiménez A, González-Beltrán D, Yévenes-Briones H, Banegas JR, Rodríguez-Artalejo F, Lopez-Garcia E, et al. Plasma metabolomic profiling and functional disability in older adults. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2026;81(5). doi:10.1093/gerona/glag054

BibTeX
@article{PomboJimnez2026,
  author = {Pombo-Jiménez, Andrés and González-Beltrán, Damián and Yévenes-Briones, Humberto and Banegas, José R and Rodríguez-Artalejo, Fernando and Lopez-Garcia, Esther and Caballero, Francisco Félix},
  title = {Plasma metabolomic profiling and functional disability in older adults},
  journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
  year = {2026},
  volume = {81},
  number = {5},
  doi = {10.1093/gerona/glag054}
}
Kostenlos starten →